![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PHARMA TRIALS AND INNOVATIONS
PHARMA TRIALS AND INNOVATIONS
April 11, 2006
A Laval firm developing drugs to fight diabetes and obesity entered the industry in a novel way, and its strategy is paying off. Unlike most pharmaceutical start-ups, Innodia Inc. wasn't rolled out of a university laboratory or split off a larger drug company. Claude Vezeau, the founder of the Laval-based biopharmaceutical company, took a different approach. First, he designed the company's shell. Then, he began to search for a product.
The Gazette (http://www.canada.com/montrealgazette/news/business/story.html?id=75a13155-9152-48e2-ba70-e167857a600d&k=54145)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct